Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 3.390
+0.090 (2.73%)
At close: Mar 18, 2026
Redsense Medical AB Revenue
In the year 2025, Redsense Medical AB had annual revenue of 26.80M SEK, down -6.84%. Redsense Medical AB had revenue of 7.65M in the quarter ending December 31, 2025, a decrease of -39.73%.
Revenue
26.80M
Revenue Growth
-6.84%
P/S Ratio
2.02
Revenue / Employee
6.70M
Employees
4
Market Cap
54.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.80M | -1.97M | -6.84% |
| Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
| Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
| Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
| Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SolidX AB | 143.51M |
| Lightning Group AB | 64.14M |
| QBNK Holding AB | 41.24M |
| Touchtech AB | 22.42M |
| Genetic Analysis AS | 19.36M |
| Vidhance AB | 17.99M |
| Monivent AB | 4.53M |
| Smoltek Nanotech Holding AB | 4.20M |